-
Australia's new Ghost Shark submarines grow some 'teeth'
-
China's third-quarter growth narrowly beats forecasts
-
'I call it a bribe': Pennsylvania residents spurn $10,000 data center checks
-
Asian stocks start week on back foot, tracking tech-led Wall St losses
-
In a former US steel city, ordinary people struggle to get by
-
China growth narrowly beats forecasts
-
'Liar,' 'clown': Lula and Bolsonaro spar in Brazil poll debate
-
Faith and fury: Texas Senate rivals offer contrasting visions
-
Record El Nino? Depends who's counting
-
Women await justice for police killings in Brazil
-
On the front line of ocean conservation off Portugal's Madeira
-
The painstaking task of cataloguing the world's species
-
Wembanyama targets title breakthrough as NBA season tips off
-
Nations seek reset at UN talks as nature goals off track
-
With LeBron on board it's title or bust for Philly fans
-
Rubio seeks to strengthen US foothold in Central Asia
-
One year after Louvre heist, where are the missing jewels?
-
LeBron joins 76ers to chase one more NBA title at age 41
-
Knicks face tall task in NBA championship repeat bid
-
Rays one win from World Series return after downing Guardians
-
Warriors' Curry 'fine' after limping out of practice - Kerr
-
Kings' Ben Simmons tears Achilles in training
-
Zelensky speaks to US envoys as Trump lashes out
-
Lula, Bolsonaro set for first debate showdown in bitter election race
-
'Surprise package' Lazio crush Juve to keep pace with Serie A leaders Inter
-
Mbappe hits two as Real Madrid rout Sevilla
-
China growth expected to miss official target in third quarter
-
Browns edge Ravens for division lead, Texans beat Jags
-
Lazio crush Juventus to move level with Serie A leaders Inter
-
Lyon go top of Ligue 1 as Monaco fall to first defeat of the season
-
Leeds draw feels like 'fresh start' for Man Utd's Carrick
-
Venezuela opposition alliance reaffirms Nobel laureate Machado as leader
-
Macron denounces 'unbridled' violence as France hit by new clashes
-
'Street Fighter' wins N. America box office, buzzy doc stuns in 2nd
-
Hurzeler lauds 'hard worker' Gomez after Brighton goal from halfway line
-
NFL: Paris game to go ahead despite protests in France
-
Toulouse hold off Exeter, Northampton save English Champions Cup blushes
-
Arteta hails Arsenal 'finishers' after Madueke fells Forest
-
Arsenal snatch late win to keep pressure on Man City as Man Utd held
-
Trump backs ally Netanyahu ahead of Israel's tight election
-
Arsenal strike late to keep pressure on Man City as Man Utd held
-
Madueke strikes late as below-par Arsenal sink Forest
-
Four soldiers dead, dozens injured in fire at Canada military base
-
Second day of street clashes in Milan
-
Ton-up Agha helps Pakistan down Sri Lanka in tri-series opener
-
Dupont's Toulouse hold off Exeter as English Champions Cup woes continue
-
Man Utd draw at Leeds keeps pressure on Carrick
-
Zelensky speaks to US envoys amid Trump spat
-
Barca defenders Garcia, Kounde injured before key games
-
Paris police in new battles with protesters and looters
Animal testing put to the test in Swiss vote
Switzerland goes to the polls Sunday to decide whether animal and human testing should be banned -- a proposal that has triggered an outcry in a country heavily reliant on big pharma.
Opinions suggest that the proposal by animal rights defenders is highly unlikely to pass.
But if it did, "Switzerland would be the only country internationally with such a ban," said Yves Fluckiger, president of the Swiss universities lobby group.
Researchers insist that medical progress is impossible without experimentation.
At the University of Geneva, Patrycja Nowak-Sliwinska, head of the molecular pharmacology laboratory, unveils her cell incubator where intestinal organoids from cancer patients are being cultivated.
These structures, made up of cells, make it possible to test a large number of potential treatments.
"With the in vitro model, we try to find promising candidates" -- and only the latter would then be tested on animals, said Nowak-Sliwinska, who received a prize rewarding researchers who work to replace animals with other methods.
But even she said it would be impossible to do all the research without animal experimentation and clinical trials.
This is why the university's Faculty of Medicine has an animal facility in the basement housing some 25,000 animals -- mostly mice and rats.
- Strict protocols -
Inside, Professor Doron Merkler conducts research to find a treatment for a form of multiple sclerosis.
The research could not advance without using mice, into which he injects modified cells to observe how the disease affects the nervous system.
The mouse he is working on is showing symptoms: instability, difficulty moving, and partial paralysis of the limbs.
The experiments are framed by a strict protocol regarding their degree of severity, and animal keepers are trained to detect when an animal is not well.
"If no veterinary care can be provided to the animal, we can decide with the researcher to sacrifice it," said Pierre Bonnaventure, head of animal facilities at the faculty.
In Switzerland, researchers seeking to use live animals must make a formal request, establish that there is no alternative method available and that the conditions imposed on the animals will be as light as possible.
The number of animals used has consequently fallen sharply, from nearly two million per year in the early 1980s to around 560,000.
Some 20,000 animals a year undergo severe interventions, such as the implantation of a tumour, according to federal authorities.
- Proposal 'goes too far' -
Under Switzerland's direct democracy system, campaigners collected enough signatures to trigger a popular vote.
The proposal would outlaw experiments not only on animals but on humans too, as well as ban the importation of new drugs developed through such means.
"Animal experiments should be considered a crime," Renato Werndli, a doctor among those who launched the initiative, told AFP.
All the major political parties in Switzerland are against the proposal.
For the government, the ban "goes too far" and would have "serious consequences for health" -- and also for the economy, in a country where the chemical and pharmaceutical sector represents just over half of all exports.
Interpharma, the Swiss pharmaceutical industry's lobby group, warned that in the event of a ban, "the institutions and companies concerned would be forced to relocate their activities abroad".
Switzerland has already rejected three initiatives on the subject -- in 1985 (70 percent), 1992 (56 percent) and 1993 (72 percent) -- and is expected to do likewise this time.
But it remains to be seen whether the majority will be as big, in a society where animal welfare has grown in importance.
For Samia Hurst, a bioethicist at the University of Geneva, the new initiative commits "a fairly frequent mistake, which is to target biomedical research".
However, she told AFP: "Animal experimentation, among the various uses that humanity makes of other species, is both the most closely monitored and undoubtedly the most justified."
O.Norris--AMWN